Life science investor group, Novo Holdings, has agreed to buy Ritedose, the largest sterile CDMO in the US focused on advanced blow-fill-seal technology, from Hong-Kong based, AGIC Capital, and China’s Humanwell.
Symbiosis values time as much as you do. We offer rapid access to fill/finish manufacturing slots and have extensive expertise and experience across vaccines, ATMPs, mAbs and much more.
A leader from the drug development and manufacturing firm talks about the ways in which advanced digital tools stand to revolutionize the pharma field.